Visibility Score
100/100
AI Mentions
145
AI Search Volume
162.8K
Impressions
19.6M
As of March 7, 2026, Truveta (truveta.com) has an AI visibility score of 100 out of 100, based on 145 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 162.8K AI search volume and 19.6M impressions. On the traditional SEO side, Truveta receives an estimated 11.7K monthly organic visits with a traffic value of $108.6K. Compared to peers, Truveta ranks #3 of 5 in AI mention share of voice.
Truveta has 145 total AI mentions across 2 tracked platforms, generating 162.8K in AI search volume. Google AI Overview accounts for the largest share at 83% of mentions. AI platforms associate Truveta with 20 brand entities, including COVID-19, Centers for Disease Control and Prevention, Ozempic.
Sample questions where AI platforms cite Truveta in their responses.
Disease-modifying therapies (DMTs) for Multiple Sclerosis (MS) are medications designed to reduce relapse frequency, slow disability progression, and limit new central nervous system inflammation . Over 20 FDA-approved options exist, categorized into injections, oral pills, and infusions, generally used for relapsing forms of MS.123
Key Aspects of MS DMTs:
Disclaimer: This information is for informational purposes only and does not constitute medical advice. Consult a healthcare professional for treatment decisions.
Truveta ranks for 1.4K organic keywords, driving an estimated 11.7K monthly visits worth $108.6K in traffic value. Organic traffic has grown from 9.8K to 17.7K over the tracked period. Top ranking keywords include "disease modifying therapies" (position 52), "disease-modifying therapies" (position 34), "dmts" (position 11).
Organic Traffic
11.7K
estimated monthly visits
Organic Keywords
1.4K
ranking keywords
Traffic Value
$108.6K
estimated monthly value
Truveta ranks #3 out of 5 competitors in AI mention share of voice, capturing 6% of total mentions. IQVIA leads with 1.4K AI mentions. Competitors tracked include IQVIA, Tempus, Flatiron Health, ConcertAI.
| Company | Mentions | AI Vol |
|---|
This is a static snapshot. Get live AI visibility tracking, competitor alerts, and actionable recommendations with VayoMed Brand Monitor.
| 2 |
| 26 |
| 5 | https://www.healthline.com/health-news/mounjaro-better-ozempic-weight-loss?utm_source=chatgpt.com | 2 | 230 |
| 6 | https://www.leanova.in/blog/science-of-glp-1-drugs-2/comprehensive-comparison-semaglutide-ozempic-vs-tirzepatide-mounjaro-1?utm_source=chatgpt.com | 2 | 182 |
| 7 | https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-wegovy-cuts-heart-risk-by-57-versus-rival-lilly-weight-loss-drug-2025-08-31/?utm_source=chatgpt.com | 2 | 358 |
| 8 | https://www.theguardian.com/science/2026/jan/29/small-risk-severe-acute-pancreatitis-weight-loss-jabs-mhra?utm_source=chatgpt.com | 2 | 302 |
| 9 | https://www.truveta.com/blog/research/research-insights/real-time-monitoring-of-respiratory-virus-associated-hospitalizations-trends-through-october-2025?utm_source=chatgpt.com | 2 | 54 |
| 10 | https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON550?utm_source=chatgpt.com | 2 | 72 |
DMTs (Disease-Modifying Therapies) for Multiple Sclerosis are medications that target the immune system to reduce MS attacks (relapses), slow disease progression, and prevent disability accumulation , with options including oral pills (like Tecfidera, Gilenya), injections (like Copaxone, Kesimpta), and infusions (like Ocrevus, Tysabri). Key examples include interferon beta-1a (Avonex) , glatiramer acetate (Copaxone), natalizumab (Tysabri), ocrelizumab (Ocrevus), dimethyl fumarate (Tecfidera) , and fingolimod (Gilenya), all aiming to modify the immune system's overactivity in MS.1234
Types of DMTs by Administration
Average Newborn Weight by Month1
Newborn babies typically lose weight in the first few days after birth but then gain weight steadily over the first year.The average weight gain by month is as follows:123456789101112131415161718192021
| Month | Average Weight Gain (pounds) |
|---|---|
| 1 | 1-2 |
| 2 | 1.5-2 |
| 3 | 1.5-2 |
| 4 | 1-1.5 |
| 5 | 1-1.5 |
| 6 | 1-1.5 |
| 7 | 0.5-1 |
| 8 | 0.5-1 |
| 9 | 0.5-1 |
| 10 | 0.5-1 |
| 11 | 0.5-1 |
| 12 | 0.5-1 |
Note:1
Table of Average Newborn Weight by Month (pounds)123
| Month | Girls (50th percentile) | Boys (50th percentile) |
|---|---|---|
| Birth | 7.2 | 7.6 |
| 1 | 9.4 | 9.9 |
| 2 | 11.5 | 12.4 |
| 3 | 13.7 | 14.1 |
| 4 | 15.9 | 16.3 |
| 5 | 18 | 18.6 |
| 6 | 20.1 | 20.9 |
| 7 | 21.3 | 22.1 |
| 8 | 22.5 | 23.3 |
| 9 | 23.7 | 24.5 |
| 10 | 24.9 | 2
Yes, tirzepatide (Mounjaro/Zepbound) works very effectively for both Type 2 diabetes management (Mounjaro) and weight loss (Zepbound), often outperforming other medications like semaglutide, by reducing appetite and improving blood sugar control, with studies showing significant weight loss (up to 20%) and better A1c levels, though side effects like nausea are common.1234
How it Works:
Effectiveness:
Soccer, a physically demanding sport, is prone to various injuries.Here are some of the most common ones:1234
Lower Body Injuries:1
Upper Body Injuries:1
Other Injuries:1
Risk Factors:Poor technique, Lack of proper warm-up and cool-down, Playing on uneven surfaces, Overuse, and Previous injuries.1234567
Treatment:1
Treatment depends on the severity of the injury.Minor injuries may respond to rest, ice, compression, and elevation (RICE).More serious injuries may require surgery, physical therapy, or other medical interventions.123456
Note: It is important to consult a healthcare professional for proper diagnosis and treatment of any soccer injuries.
| Keyword | Position | Search Vol |
|---|---|---|
| disease modifying therapies | 52 | 135.0K |
| disease-modifying therapies | 34 | 135.0K |
| dmts | 11 | 135.0K |
| disease-modifying therapies for multiple sclerosis | 19 | 74.0K |
| dmt drugs for ms | 29 | 74.0K |
| dmt for ms | 6 | 74.0K |
| dmts ms | 9 | 74.0K |
| ms dmt | 9 | 74.0K |
| dmts drugs | 23 | 60.5K |
| mounjaro vs ozempic | 59 | 40.5K |
| average newborn birth weight | 19 | 18.1K |
| average newborn weight at birth | 54 | 18.1K |
| adderall shortage | 25 | 9.9K |
| tirzepatide vs ozempic | 4 | 6.6K |
| truveta | 1 | 5.4K |
| adderall shortage 2025 | 36 | 4.4K |
| football and injuries | 64 | 4.4K |
| football injuries | 41 | 4.4K |
| injuries for football | 73 | 4.4K |
| injuries from football | 46 | 4.4K |
| Impr. |
|---|
| Truveta (You) | 121 | 162.1K | 19.6M |
| IQVIA | 1.4K | 474.4K | 671.2M |
| Flatiron Health | 86 | 21.1K | 1.8M |
| Tempus | 294 | 60.2K | 17.7M |
| ConcertAI | 8 | 5.9K | 47.1K |